The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 5%. The street (3 analysts) rates it hold, with a mean price target of $693.
Boubyan Bank K.S.C.P.
BOUBYAN.KW · KUW · KWF · Market cap $3.1B
Boubyan Bank K.S.C.P., together with its subsidiaries, provides various banking products and services in Kuwait, the Middle East, North Africa, Europe, the United Kingdom, and internationally.
FAIL · Does not pass the screenPrice as of 12 Nov 2026Daily close, not a live quoteLast reviewed 5 days ago
Screened 2026-11-12 · the tape above runs as of 12:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price661.00 KWF at the 12 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 12 Nov 2026
- Our regime readAccumulation, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed12 Nov 2026 (5 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: 330.50 KWF to 431.38 KWF, base estimate 375.12 KWF (screen dated 2026-11-12).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Boubyan Bank K.S.C.P. holds its Accumulation at $661.00. Consolidating, no directional conviction, held for 69 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 69 days |
| Price at the screen | $661.00 |
| Valuation | 33.25 trailing · 33.25 forward price to earnings |
| Values screen | FAIL |
| Beta | 0.08 |
Five Screens, Shown in Full
Does not pass. Business activity: conventional financial services (interest-based)
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Its core business involves an activity the values screen does not clear. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Boubyan Bank K.S.C.P. does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-11-16. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BOUBYAN.KW's ethical verdict changes
Today BOUBYAN.KW does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 12 Nov 2026: it trades above our 375.12 KWF fair value estimate, moderate competitive moat, 5.10% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in KWF, drawn from the 2026-11-12 screen. The gold marker is the market price at the same screen. The price runs 76.2% above the base estimate.
Third-party analyst targets: 3 covering, consensus Hold. The average target sits +13% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate 375.12 KWF, with a range of 330.50 KWF to 431.38 KWF, dated to the 2026-11-12 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 33.3x forward earnings, the price already runs ahead of the business. It trades 76% above our 375.12 KWF fair value, so you would be buying at a premium, not a discount. The moderate moat is real, but quality alone does not make an expensive price cheap.
| Forward P/E | 33.3xexpensive even after accounting for its growth |
| Trailing P/E | 33.3xa premium valuation |
| EPS, trailing | 0.02 |
| EPS, forward | 0.02 |
| Revenue growth | +5.1%slow but positive growth |
| Profit margin | 39.9%highly profitable on every dollar of sales |
| Return on equity | 9.3%a modest return on shareholder capital |
| Dividend yield | 1.07% |
| Beta | 0.08barely tracks the market's swings |
| 52-week range | 616.82 - 697.20 |
| Moat | MODERATE |
| Market cap | $3.1B |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Kuwait and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBOUBYAN.KW trades on KUW (the company is based in Kuwait). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 5%. The street (3 analysts) rates it hold, with a mean price target of $693.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 5%. The street (3 analysts) rates it hold, with a mean price target of $693.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 5%. The street (3 analysts) rates it hold, with a mean price target of $693.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 5%. The street (3 analysts) rates it hold, with a mean price target of $693.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 5%. The street (3 analysts) rates it hold, with a mean price target of $693.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.7% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 5%. The street (3 analysts) rates it hold, with a mean price target of $693.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 5%. The street (3 analysts) rates it hold, with a mean price target of $693.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Kuwait Petroleum Corporation agrees to $4.9bn loan to boost oil output Offshore Technology · 18 Nov 2025
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $668.00 | -2.8% | · | $972 | -2.8% |
| 2 months | $657.00 | -1.2% | · | $988 | -1.2% |
| 3 months | $646.72 | +0.4% | $7.00 | $1,014 | +1.4% |
| 6 months | $695.32 | -6.7% | $7.00 | $943 | -5.7% |
| 1 year | $634.57 | +2.3% | $7.00 | $1,034 | +3.4% |
| 2 years | $518.01 | +25.3% | $16.35 | $1,284 | +28.4% |
| 3 years | $523.11 | +24.1% | $23.47 | $1,286 | +28.6% |
| 5 years | $499.99 | +29.8% | $32.26 | $1,363 | +36.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BOUBYAN.KW does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.